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Abstract: Herbal medicine is now globally accepted as a valid alternative system of pharmaceutical
therapies. Various studies around the world have been initiated to develop scientific evidence-based
herbal therapies. Recently, the therapeutic potential of medicinal plant derived miRNAs has attracted
great attraction. MicroRNAs have been indicated as new bioactive ingredients in medicinal plants.
However, the stability of miRNAs during the herbal preparation process and their bioavailability
in humans remain unclear. Viscum album L. (European mistletoe) has been widely used in folk
medicine for the treatment of cancer and cardiovascular diseases. Our previous study has indicated
the therapeutic potential of mistletoe miRNAs by using bioinformatics tools. To evaluate the stability
of these miRNAs, various mistletoe extracts that mimic the clinical medicinal use as well as traditional
folk medicinal use were prepared. The mistletoe miRNAs including miR166a-3p, miR159a, miR831-5p,
val-miR218 and val-miR11 were quantified by stem-loop qRT-PCR. As a result, miRNAs were
detectable in the majority of the extracts, indicating that consumption of medicinal plant preparations
might introduce miRNAs into mammals. The factors that might cause miRNA degradation include
ultrasonic treatment, extreme heat, especially RNase treatment, while to be associated with plant
molecules (e.g., proteins, exosomes) might be an efficient way to protect miRNAs against degradation.
Our study confirmed the stability of plant derived miRNAs during herb preparations, suggesting the
possibility of functionally intact medicinal plant miRNAs in mammals.
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1. Introduction
Medicinal preparations derived from natural sources, especially from plants, have been in
widespread use since ancient times. Herbal medicine is globally accepted as a valid alternative
system of therapy in the form of pharmaceuticals or functional foods. Although ancient medical
treatises have documented a large number of medicinal plants, their bioactive constituents and
corresponding interactions with human have not been comprehensively characterized. New plant
bioactive molecules are being discovered. MicroRNAs (miRNAs) are a class of approximately 22
nucleotides single-stranded non-coding RNA molecules that play crucial roles in gene expression.
In 2012, Zhang et al. suggested that the rice miRNAs might enter the mammalian bloodstream and
play a functional role in human metabolism [1], providing the first clue that plant miRNAs might
impact human health and diseases. Several follow-up studies have supported this finding. MIR2911,
which was highly stable in the honeysuckle (Lonicera japonica Thunb.) decoction, could be able to
enter the lungs of the animals that fed with honeysuckle decoction, where it could directly target
various influenza A viruses, suppress their replication process, and protect the mice from influenza
infections [2]. Plant miR159, derived from raw or cooked vegetables (e.g., broccoli, soybean), was
more abundant in healthy donors in comparison to breast cancer patients [3]. By targeting 3′UTR of
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transcription factor 7, miR159 significantly suppressed breast cancer cell growth in vitro and in vivo [3].
These studies suggested that plant miRNAs might be absorbed by mammals and regulate mammalian
gene expression. We assume that, in medicinal plants, miRNAs might act as the hidden bioactive
ingredients that are involved in the therapeutic effects of medicinal plants [4].
One crucial concern regarding functional plant miRNAs is their stability in the preparation process.
A commonly held belief is that medicinal plants undergo extensive preparations such as grinding and
boiling process, allowing the release of cellular RNase or the generation of extreme heat, which might
cause the enzymatic breakdown or thermal degradation of miRNAs. Indeed, the majority of miRNAs
were degraded in medicinal plants (e.g., honeysuckle) decoction after boiling for 30 min [2]. However,
some dietary plant derived miRNAs (e.g., miR166, miR167, miR168 and miR159) were reported to be
degradation resistant, as evidenced by storage, cooking, extremes of pH (e.g., simulated gastric fluid
with pH of 1.2) and frequent bowel movement did not abolish miRNAs presented in dietary plants
such as rice, soybean, potato, broccoli and cabbage [1,3,5]. Medicinal plants usually undergo various
intensive treatments including grinding, drying, soaking, boiling and mechanical treatment. Whether
herbal miRNAs could survive these processes, and to what extent miRNAs might be degraded during
these treatments, remain to be elucidated.
Viscum album L. (V. album, Salantaceae, European mistletoe) has been widely used for the treatment
of cancer and cardiovascular diseases in Europe. Our previous study indicated that V. album miRNAs
might be able to regulate some human diseases, especially cancer, cardiovascular diseases and
neurological disorders, acting as one of the potential bioactive ingredients in V. album [6]. It is
essential to determine the stability of mistletoe miRNAs during the herb preparation process.
In this study, we prepared different mistletoe extracts according to the clinical medicinal use as
well as the folk medicinal use of mistletoe. The RNAs were isolated and miRNAs were quantified from
these extracts. We found that, although the RNA lost its integrity during the whole herb preparation
process, some miRNAs survived grinding, drying, storage, and soaking procedures. Being exposed
to RNase and ultrasonic treatment might be the major causes for miRNA degradation, while being
associated with plant derived macromolecules such as proteins and nanoparticles might protect plant
miRNAs during the herb preparation process.
2. Results
2.1. Total RNA Isolation from Raw Herb Materials and Herb Preparations
The yields and purity of total RNA obtained from mistletoe plants and mistletoe extracts were
shown in Table 1. The fresh plant generated high yield of total RNA with 630 µg/g. Interestingly, RNA
also presented in the lyophilized extract made from fresh mistletoe plant with the yield of 1404 µg/g.
A slightly decreased yield of RNA (1236 µg/g) was found after mechanical treatment. As one gram of
lyophilized extract was roughly produced from 5 g of mistletoe plant, which indicated that the fresh
mistletoe plant released at least approximate 39–45% of RNA molecules into the water in which the
plant was processed.
Table 1. Comparison of RNA isolated from mistletoe plants and lyophilized mistletoe extracts.












RNA yield (µg/g) 630.3 ± 73.5 1404.5 ± 531.2 1236.9 ± 482.8 398.2 ± 109.3 931.8 ± 212.7 26.9 ± 7.3
A260/A280 2.10 ± 0.03 2.04 ± 0.05 2.00 ± 0.07 2.02 ± 0.04 1.97 ± 0.03 1.67 ± 0.11
A260/A230 2.31 ± 0.16 2.44 ± 0.09 2.54 ± 0.09 2.30 ± 0.33 2.18 ± 0.15 0.80 ± 0.25
Sampling and analysis were carried out three independent times. The data regarding mistletoe extracts were
extrapolated from dry weight.
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The total RNA isolated from prepackaged dried mistletoe plant revealed yield of 398 µg/g.
After being soaked in the hot water for 10 min, 47% of RNA (1 g of lyophilized extract was roughly
produced from 5 g of raw plant materials) was dissolved into the water with an average amount of
931 µg/g. In agreement with previous studies [2], very low amount of RNA (27 µg/g) was obtained
from the extract boiled for 30 min, indicating the severe degradation of RNA after 30 min boiling.
The RNA purity was evaluated spectrophotometrically at the absorbance 230, 260 and 280 nm,
either low A260/A280 (<1.8) or low A260/A230 (<2.0) value indicated contamination. As shown in
Table 2, the RNA isolated from fresh plant, dried plant and various mistletoe preparations showed
A260/A280 values around 2.0, and A260/A280 values ranging from 2.2 to 2.5, suggesting the high
purity of RNA. However, the total RNA isolated from boiled extract had a low A260/A280 ratio of 1.67
and a low A260/A230 value of 0.8. Proteinase K (Thermo Scientific, Waltham, MA, USA) treatment
did not increase these ratios (data not shown), while no conspicuous absorption was observed at
270 nm (data not shown), indicating, rather than protein or phenol contamination, that these low
A260/A280 and A260/A230 values might be caused by the much lower concentration of total RNAs in
this extract [7].
RNA integrity was determined by electrophoresis in 1.2% (w/v) agarose gel. The RNA from
fresh plant showed sharp, clear 28S and 18S rRNA bands, and the 28S rRNA band was approximately
twice as intense as the 18S rRNA band (Figure 1), indicating the intactness of the RNA from fresh
plant. While the intensity of 18S rRNA was stronger than that of 28S rRNA in the RNA isolated from
mistletoe extracts made from fresh plants, indicating the degradation of total RNA in these extracts.
The RNA isolated from dried plants showed weak rRNA bands and a smeared appearance, suggesting
degradation of RNA in dried mistletoe plants. Highly smeared RNA was observed in the mistletoe
extract made by soaking dried plant at 80 ◦C, while bands were barely observed in the RNA isolated
from boiling extract, suggesting the degradation of RNA during herb preparation procedures. These
results suggested that raw mistletoe plants did release RNA molecules into the water in which the
plant was processed, but the enzymatic environment, mechanical treatment as well as heat treatment
might encourage the breakdown of total RNA.
Figure 1. Quality assessment of total RNA isolated from mistletoe preparations by agarose gel
electrophoresis. Lane 1: RNA isolated from fresh plant (FP); Lane 2: RNA isolated from mistletoe extract
made from FP; Lane 3: RNA isolated from mistletoe extract made from FP treated with mechanical
treatment; Lane 4: RNA isolated from dried mistletoe plant (DP); Lane 5: RNA isolated from mistletoe
extract made by soaking DP in 80 ◦C water for 10 min; Lane 6: RNA isolated from mistletoe extract
made by boiling DP for 30 min.
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Copy Number of miRNAs per Gram of Mistletoe Plants and Lyophilized Extracts








miR166a-3p 13.1–28.5 1 nM–10 fM 5.0 × 1011 ± 8.3 × 1010 7.4 × 109 ± 4.6×109 1.4 × 109 ± 3.0 × 108 1.2 × 1010 ± 6.1 × 109 4.2 × 108 ± 2.4 × 108 NC
miR159a 17.8–32.9 1 nM–10 fM 3.9 × 1011 ± 1.2 × 1011 1.1 × 1010 ± 5.3 × 109 3.4 × 109 ± 2.0 × 109 1.4 × 1010 ± 3.3 × 109 6.3 × 107 ± 3.0 × 107 NC
val-miR218 15.4–33.0 1 nM–10 fM 7.9 × 109 ± 3.2 × 109 6.3 × 109 ± 3.3 × 109 2.0 × 109 ± 1.5 × 109 3.6 × 109 ± 1.8 × 109 NC NC
val-miR11 20.7–32.6 100 pM–10 fM 1.2 × 108 ± 6.4 × 107 4.2 × 107 ± 2.9 × 107 NC 2.4 × 107 ± 1.2 × 107 NC NC
miR831-5p 15.6–32.7 1 nM–1 fM 3.3 × 107 ± 1.1 × 107 7.9 × 106 ± 3.3 × 106 2.9 × 106 ± 7.2 × 105 1.9 × 107 ± 6.1 × 106 NC NC
has-let-7a 20.9–32.7 100 pM–10 fM NC NC NC NC NC NC
Analyses were carried out three independent times. The data regarding mistletoe extracts were extrapolated from dry weight. The miRNA copies were extrapolated from dry weight.
NC represents not calculated (the Ct values were outside the linear range). RT represents room temperature.
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2.2. The Stability of miRNA during the Herb Preparation Process
To investigate the stability of mistletoe miRNAs during the herbal preparation process, several
high expressed miRNAs including miR166a-3p, miR159a, miR831-5p, val-miR218 and val-miR11
were quantified in various mistletoe preparations by qRT-PCR. To determine the specificity of each
primer set, no template controls (NTCs) for each miRNA were assessed simultaneously. The miRNAs
were consistently and efficiently amplified in mistletoe plants and the majority of extracts. However,
in the boiled extract, Ct values of miR166a-3p, miR159a, and miR831-5p cannot be distinguished from
those of the corresponding NTCs (Figure 2). The Ct values of val-miR11 in the boiled extract, extract
prepared as a tea, and the NTC cannot be distinguished with each other as well, suggesting that these
miRNAs in corresponding extracts cannot be quantified by qRT-PCR.
Figure 2. The raw Ct values of miRNAs in mistletoe plants and lyophilized mistletoe extracts detected
by qRT-PCR. The Ct values of val-miR218 and hsa-let-7a in the NTCs were undetectable (Ct > 39).
Sampling and analysis were carried out three independent times. The data regarding mistletoe
extracts were extrapolated from dry weight. NTC represents no-template controls. RT represents
room temperature.
To obtain the amount of plant miRNAs in different mistletoe preparations, each synthetic
single-stranded miRNA was serially diluted and assessed using qRT-PCR to generate a standard
curve. For each miRNA, the linear range of the Ct value and the dynamic quantification range of the
expression level were listed in Table 2. As negative controls, the Ct values of human miRNA hsa-let-7a
in the mistletoe plants and extracts were outside the linear range, confirming the specificity of the
stem-loop qRT-PCR. The levels of each miRNA in mistletoe plants and extracts were calculated based
on the reference to their corresponding standard curve (Supplementary Figure S1).
In agreement with our previous results [6], among tested miRNAs, miR166a-3p was the most
abundant miRNA in fresh plants, followed by miR159a, val-miR218, val-miR11, and miR831-5p,
respectively (Table 2). The miRNA profiles of dried plants and mistletoe extracts were different from
that of fresh plants. MiR159a showed the highest copy number in dried plants and it remained the top
level in extracts made from fresh plants, while miR166a-3p, val-miR11 and mi831-5p showed relatively
low levels.
As expected, the miRNAs showed the highest levels in fresh mistletoe plants, ranging from
miR831-5p with copy number of 3.3 × 107 per gram to miR166a-3p with copy number of 5.0 × 1011 per
gram. A significant decrease of miRNAs was observed in the extracts made from fresh plants. Since
50 mL of aqueous extract made from 5 g of raw plant materials produced approximately 1 g of
lyophilized extract, compared with fresh plants, 0.3% miR166a-3p, 0.6% miR159a, 15.9% val-miR218,
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7.0% val-miR11 and 4.8% miR831-5p remained in the extracts. The reduced levels of miRNAs
might be caused by the degradation of miRNAs, while the incomplete release of miRNAs from
crushed plants to the extract should be also taken into account. Medicinal plants often treated with
mechanical treatments such as magnetic stir and ultrasonic agitation to better dissolve their bioactive
components into the solvents they processed. Unexpected, mechanical treatment led to a significant
decrease of miRNA amount. Compared with the extract without mechanical treatment, the amount
of miR166a-3p, miR159a, val-miR218 and miR831-5p reduced by 81.1%, 69.1%, 68.3% and 63.3%,
respectively, indicating that mechanical treatment might not enhance the release of miRNAs into a
solvent, but increase miRNA damage.
A relatively high number of tested miRNAs were found in prepackaged dried mistletoe plants,
with copy numbers ranging from 1.9 × 107 to 1.2 × 1010, indicating that these miRNAs could survive
air-drying and storage process. The dried mistletoe was soaked in hot water for 10 min to mimic the
tea preparation. Indeed, the miRNAs were released from the raw materials to the water, but only
miR166a-3p and miR159a with relatively low levels of 4.2 × 108 and 6.3 × 107 copies per gram were
determined in the tea preparation. The Ct values of tested miRNAs in mistletoe decoction (boiled in
water for 30 min) were either undetectable or outside the linear range. Apart from exposing to RNase
and incomplete release of miRNAs from raw materials, heat might induce decrease of miRNAs as well.
2.3. The Stability of Synthetic miRNAs
Plant miRNAs might be associated with other molecules such as lipids, proteins and polysaccharides
or be loaded into miRNA carriers such as exosomes, microvesicles, and protecting the miRNAs from
degradation. On the other hand, 2′-O-methylation in plant miRNAs might also enhance their stability.
To investigate whether free miRNAs could survive herb processing and the impact of 2′-O-methylation
on miRNA stabilities, hsa-let-7a and hsa-let-7a with 2′-O-methylation were synthesized. These miRNAs
were added to mistletoe extracts and processed with same conditions. As shown in Table 3 the Ct values
of hsa-let-7a and 2′-OMe hsa-let-7a increased from approximately 23 (controls) to 33–37 (processed
together with mistletoe extracts) that were outside the linear range (20.9–32.7), indicating negligible
levels of synthetic miRNAs remained in the extracts. Compared with val-miR218 that showed a
comparable Ct values (24.84 ± 0.81) in the starting raw materials, synthetic miRNAs underwent
more intensive degradation during herb processing, suggesting that miRNAs that are free from any
plant-derived molecules were susceptible to degradation. The 2′-O-methylation in plant miRNAs
might help, but not enough to resist degradation in harsh environments.
Table 3. The Ct values of synthetic miRNAs processed together with mistletoe preparations.
Synthetic
miRNAs Control












hsa-let-7a 23.34 ± 0.47 34.81 ± 0.32 35.78 ± 0.79 35.63 ± 0.35 37.71 ± 0.58
2′-OMe hsa-let-7a 23.08 ± 0.43 33.09 ± 0.24 35.30 ± 0.30 35.28 ± 0.70 37.14 ± 0.69
Sampling and analysis were carried out three independent times.
During the herb processing, drying, mechanical treatment, heat, and RNase that released from
damaged plant cells might lead to the miRNA degradation. To explain the possible causes for
miRNA degradation, synthetic miRNAs were treated with aforementioned conditions. As shown in
Figure 3, comparable Ct values of both hsa-let-7a and 2′-OMe hsa-let-7a were found after lyophilization,
intensively shaking and incubation at 80 ◦C, indicating simple drying, frequent movement and a
certain degree of heat (less than 80 ◦C) might not be able to cause miRNA damage. After incubation at
100 ◦C for 30 min, a significant decrease (50%; 1-1/222.4–21.4) of hsa-let-7a was observed, while 2′-OMe
hsa-let-7a remained stable, indicating that methylation of miRNAs could enhance their heat stabilities.
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Ultrasonic treatment induced intensive degradation of miRNAs, and a significant reduction of both
hsa-let-7a (93%; 1-1/225.3–21.4) and 2′-OMe hsa-let-7a (80%; 1-1/224.2–21.8) were detected after ultrasonic
treatment. Moreover, almost complete damage of miRNAs was observed after RNase treatment.
More than 99% of hsa-let-7a (99.98%; 1-1/233.8–21.4) and 2′-OMe hsa-let-7a (99.95%; 1-1/232.9–21.8) were
digested by RNase. These results indicated that being exposed to RNase might cause a large extent
degradation of plant miRNAs, while intensive mechanical treatment such as ultrasonic treatment
might also induce severe damage of plant miRNA. On the other hand, methylation of plant miRNAs
could enhance their resistance against heat, ultrasonic agitation and RNase digestion, but were not
strong enough to protect miRNAs against the whole extreme environment.
Figure 3. The Ct values of synthetic miRNAs with various treatments. Sampling and analysis were
carried out three independent times. “*” represents a significant difference compared with untreated
group (p < 0.05); “#” represents a significant difference between hsa-let-7a and 2′-OMe hsa-let-7a group
(p < 0.05).
3. Discussion
Plants have been used for medicinal purposes long before recorded history. However, the bioactive
ingredients and their regulatory function remain to be discovered. In recent years, plant miRNAs as
new bioactive constituents have attracted great attention. Rice miRNAs could enter the mammalian
bloodstream and play a functional role in human metabolism [1]. The MIR2911 from honeysuckle was
found to target influenza viruses and protect mice from influenza infections [2]. Plant derived miR159
significantly suppressed breast cancer cell proliferation by targeting transcription factor 7 (TCF7) [3].
Oral application of a cocktail that consisted of plant-based tumor suppressor miRNAs suppressed
tumor burdens in mice [8]. It is well known that medicinal plants usually undergo extensive treatment
such as grinding, drying, storage, soaking or boiling process before they are digested in vivo. As the
potential bioactive ingredients, the stability of miRNAs during herb preparations is the precondition
allowing them to function in vivo. Our previous study indicated that mistletoe miRNAs might
be associated with its pharmacological effects such as anti-tumor, cardiovascular protective and
neurological protective effects [6]. In this study, we tested the stability of mistletoe miRNAs in different
mistletoe preparations.
As a frequently used adjuvant in cancer therapy, V. album extracts are commercially available in
Europe [9], such as Isorel, abnobaVISCUM and Helixor. The majority of these commercial extracts
use fresh or well-preserved (stored in liquid nitrogen) mistletoe as starting materials. As indicated by
some companies (e.g., abnobaVISCUM), ascorbate phosphate buffer may ensure high yield of main
ingredients (mistletoe lectins, viscotoxins). Accordingly, we prepared two extracts from fresh mistletoe
plant with ascorbate phosphate buffer as the extract solution.
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All the tested mistletoe miRNAs were found abundance in the fresh extracts (Table 2), even the
amount reduced after ultrasonic treatment, some mistletoe miRNAs at levels of femtomolar per gram
remained in the extracts. Commercial mistletoe extracts are often applied by intra-tumoral injection, or
less often, subcutaneous injection or intravenous infusion [10], which display high bioavailability and
facilitate rapid absorption. Injection of mistletoe extracts two to three times a week (20 mg per time)
might introduce miR166a-3p (0.25 fmol; 7.4 × 109 × 0.02 copies; for each injection), miR159a (0.37 fmol;
1.1 × 1010 × 0.02 copies; for each injection) and val-miR218 (0.25 fmol; 6.3 × 109 × 0.02 copies; for
each injection) at levels of attomolar or femtomolar into the tumor tissue or circulating system. It was
reported that plant miRNAs could exert regulatory effects in animals at plasma concentration of
fM [1,3]. Therefore, biologically relevant mistletoe miRNAs might probably be achieved via injection of
commercial mistletoe extracts. Further animal experimental studies and even clinical data are needed
to confirm the possibility of biologically relevant of plant miRNAs in mammals.
Dried mistletoe is widely available as a therapeutic herbal tea in continental Europe. Our results
suggested that some mistletoe miRNAs (e.g., miR166a-3p and miR159a) were presented in mistletoe
tea. Theoretically, 250 mL of hot mistletoe tea prepared from 5 grams of chopped mistletoe leaves may
contain (a liquid mistletoe extract made from 5 g of dried mistletoe leaves could roughly create 1 g of
lyophilized extract) 0.7 fmol (4.2× 108 copies) of miR166a-3p and 0.1 fmol (6.3× 107 copies) of miR159a.
The bioavailability of these miRNAs after oral application remains to be elicited. A previous study
indicated that plasma MIR2911 reached to a peak concentration of 1189 fM at 6 h after single gavage
feeding of mice by honeysuckle decoction that contained 60 fmol (3.6 × 1010 copies) of MIR2911 [2].
The miR168a was presented in mouse liver and plasma after three days feeding with chow diet
containing about 100 pmol (6.02 × 1013 copies) of miR168a [1]. Liang et al. described that the plant
miRNAs including miR156a, miR162a, miR168a, miR172a, miR390a and miR528 were detected at fM
levels in healthy human plasma after consumption of fruit juice with miRNA absorption rates of 0.04%
to 1.31% [11], indicating miRNAs might have low bioavailability after oral application. Therefore,
single consumption of mistletoe tea might not lead to the detectable plant miRNAs in human plasma.
However, low bioavailability of plant miRNAs after oral application could not deny their bioactive
potential. It has been indicated that miRNAs can act as hormones and execute their functions at several
hundred copies per cell [1,12,13]. The bioavailability and therapeutic potential of mistletoe miRNAs
through oral application remain to be validated.
It is noteworthy that, during the herbal preparation process, the degree of miRNA degradation
varied among different miRNAs. For example, after mechanical treatment, the miR159a, val-miR218
and miR831-5p decreased by 69.1%, 68.3% and 63.3%, respectively, in the extract made from fresh
plant, while 81.1% miR166a-3p was degraded (Table 2), indicating that miR166a-3p might be more
sensitive to degradation. Meanwhile, even miR166a-3p showed a higher amount than miR159a in
fresh mistletoe plant, and miR159a was found to have the largest copy number in various mistletoe
preparations and extracts, indicating that they might be partnered with different molecules, which
have different abilities to protect their integrity.
In addition, our results suggested that miRNAs degradation might attribute to the total RNA
degradation during the herb preparing process. Similarly, the mice miRNAs (e.g., miR-122) were found
degraded in total RNAs with low integrity, which were isolated from long-term stored frozen liver
tissues [14]. In contrast, even RNA lost integrity in processed, cooked and in vitro digested soybean
samples, and much higher levels of miRNAs (e.g., miR166, miR167 and miR168) were detected in
the processed soybeans compared with the raw, uncooked beans [5]. It appeared that whether total
RNA degradation correlated with miRNA degradation varied among different tissues and species,
the matrix that miRNAs associated with might play a significant role, such as plant seeds that are rich
in proteins and fat might offer more effective protection of miRNAs during plant processing.
Previous studies have explained the robustness of plant miRNAs. The 2′-O-methylated at their
3′ ends enhances their stability by protecting them from enzymatic digestion [15]. Plants are usually
rich in secondary metabolites that may disrupt RNase activity and protect plant miRNAs from
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enzymatic environments [16–18]. Plant miRNAs are associated with RNA-binding proteins such as
Argonaute proteins (AGOs) or encapsulated in nanoparticles such as exosomes and microvesicles,
which might protect miRNAs from degradation [19–21]. In this study, methylated hsa-let-7a cannot
survive enzymatic environments (e.g., RNase treatment and various mistletoe extracts), indicating
that methylation of plant miRNAs might not be the key factor that keeps them stable during herb
preparations. Furthermore, synthetic miRNAs degraded rapidly when they processed together with
the mistletoe preparations (Table 3), indicating that the secondary metabolites in the extracts could not
efficiently protect the miRNAs from degradation.
4. Materials and Methods
4.1. Plant Materials
One-year old V. album leaves and stems were collected at Berlin Botanical Garden in July
2017. The fresh mistletoe plants were snapped in liquid nitrogen and stored at −80 ◦C until use.
Prepacked dried V. album leaves and stems of regular consumer standard were purchased from Alfred
Galke GmbH, Bad Grund, Germany. They were collected in January 2015, air-dried, and stored at
room temperature.
4.2. Preparations of Mistletoe Extracts
To mimic clinical use of mistletoe extracts, V. album fresh leaves and stems were grinded in
liquid nitrogen. Five grams of powdered fresh mistletoe were added to 50 mL of extraction buffer
(19.30 mM of Ascorbic acid, 1.31 mM of NaH2PO4·H2O, 11.34 mM of Na2HPO4·2H2O, and 17.35 mM of
Na3PO4·12H2O, adjust pH of 7.5), mixed well, and centrifuged at 10,000× g for 20 min. The supernatant
was then passed through 0.22 µm syringe filter and lyophilized. To evaluate the impact of mechanical
damage during herb preparations, the powdered fresh mistletoe plant was added to an extraction
buffer, treated with magnetic stir for 30 min, and then followed by ultrasonic treatment for a total of
30 min (10 min × 3 times). The resultant extract was centrifuged, filtered and lyophilized.
The prepacked dried V. album leaves and stems were ground to a fine powder using a homogenizer
at room temperature. To mimic the typical European use of mistletoe as tea, 5 g of powdered plant
materials were soaked in 50 mL of hot water (approximate 80 ◦C) for 10 min. To mimic the traditional
Chinese preparations of herbs, 5 g of powdered mistletoe was boiled in 50 mL of RNase-free water
(approximate 100 ◦C) for 30 min. These extracts were then centrifuged at 10,000× g for 20 min, and the
supernatants were lyophilized and used for RNA isolation.
4.3. RNA Isolation
The fresh mistletoe leaves and stems were finely powdered by grinding in liquid nitrogen.
The dried powdered plants and lyophilized extracts were weighed and processed for RNA isolation.
Total RNA was extracted using RNA-Bee RNA isolation reagent (Amsbio, Abingdon, UK) according
to the manufacturer’s protocol with slight modifications. Briefly, 100 mg of plant samples were mixed
with 1 mL of RNA-Bee thoroughly, 0.2 mL of chloroform was added to the mixture, and centrifuged at
12,000× g for 20 min. The mixture was extract twice with chloroform, and the RNA was precipitated
with half volume high salt solution (0.8 M sodium citrate, 1.2 M NaCl) and half volume isopropyl
alcohol [22]. After washing twice with 75% ethanol, the RNA precipitate was dissolved in RNase-free
water. Genomic DNA traces were eliminated using DNase I (Promega, Madison, WI, USA).
The quantity and quality of the RNA obtained were assessed spectrophotometrically at 230,
260 and 280 nm (Eppendorf, Hamburg, Germany). The A260/280 ratio was used to detect the
contamination with DNA and proteins, while the A260/230 ratio was used to check for carbohydrate
or phenol contamination. Quality and integrity of isolated RNA were verified by electrophoresis in
1.2% (w/v) agarose gel.
Molecules 2018, 23, 919 10 of 12
4.4. qRT-PCR
Five mistletoe miRNAs were selected and validated by qRT-PCR as previously described by
Chen et al. [12]. The stem-loop primers for reverse transcription and primers for PCR were listed in
Table 4. First-strand cDNA synthesis was performed using a TaqMan MicroRNA Reverse Transcription
Kit (Thermo Scientific, Waltham, MA, USA) according to the manufacturer’s protocol. The reaction
was carried out at 16 ◦C for 30 min, at 42 ◦C for 10 min, followed by heat-inactivation at 85 ◦C for
5 min.
Table 4. Primers for stem-loop qRT-PCT.






















GTCGT ATCCA GTGCA GGGTC CGAGG








Quantitative real-time PCR was conducted using the PowerUp™ SYBR® Green Master Mix
(Thermo Scientific) and PikoReal Real-Time PCR System (Thermo Scientific). The reactions were
carried out with the following amplification conditions: activation at 50 ◦C for 2 min, 95 ◦C for 2 min,
followed by 40 cycles of denaturation at 95 ◦C for 15 s, annealing at 55 ◦C for 15 s, and extension then
at 72 ◦C for 30 s. All reactions were performed in three independent biological samples with three
technical repeats. The melting curve was generated to test the specificity of PCR products and avoid the
false-positive peaks. NTCs were included in all reactions. The Ct values were converted into absolute
copy numbers using a standard curve that was independently generated with known quantities
of the corresponding synthetic miRNA oligonucleotides (Metabion International AG, Steinkirchen,
Germany).
4.5. Treatment of Synthetic miRNAs
The miRNA hsa-let-7a and hsa-let-7a with 2-O-methylation at the 3′ end nucleotide,
which mimicked the chemistry of plant-derived miRNAs, were synthesized by Metabion International
AG (Steinkirchen, Germany).
To investigate the possible factors that might cause miRNAs degradation, 50 µL of synthetic
miRNA (100 pM) were treated with the following conditions: lyophilized and re-dissolved in 50 µL of
RNase-free water; shook at room temperature by an orbital shaker incubator (Thermo Scientific) for
30 min; incubated in ultrasonic bath at room temperature for 10 min × 3 times; incubated at 80 ◦C in
water bath for 10 min; and boiled at 100 ◦C for 30 min. For RNase treatment, 8 µL of synthetic miRNAs
(125 pM) was incubated with 10 U of RNase If (New England Biolabs, Ipswich, MA, USA) in 1× Buffer
in a total reaction volume of 10 µL at 37 ◦C for 30 min. The RNase was then inactivated by incubating
at 70 ◦C for 20 min. After treatment, the synthetic miRNAs were cooled down on ice, spun down,
and used for cDNA synthesis and qRT-PCR.
To investigate if synthetic miRNAs could survive the simulated conditions of herb processing,
synthetic miRNAs were dissolved in RNase-free water, and processed together with mistletoe plants.
Specifically, 25 µL of synthetic miRNAs (100 pM) was added to 1 mL of extracts made from fresh plants,
then treated with or without mechanical treatment (including magnetic stir and ultrasonic treatment);
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or soaked in 1 mL of hot water (approximate 80 ◦C) containing dried powdered mistletoe for 10 min;
or boiled with 1 mL boiling water containing dried powdered mistletoe for 30 min. The extracts were
then centrifuged and lyophilized. The RNAs were isolated and dissolved in 25 µL of RNase-free water,
and used for miRNA quantification.
4.6. Statistical Analysis
All data represent mean ± SD. Two-tailed Student’s t-tests were used to assess statistical
significance. Values of p < 0.05 were considered significant.
5. Conclusions
This study evaluated the stability of mistletoe miRNAs during the herb preparation process.
Even mistletoe miRNAs underwent intensive degradation during drying, storage, and extraction
procedures, and the miRNAs with a large copy number were detected in the majority of mistletoe
preparations. Injection of commercial mistletoe extracts made from fresh plants may facilitate a
biologically relevant level of mistletoe miRNAs in patients’ tissues or circulating systems. However,
single consumption of mistletoe tea made from dried chopped leaves might not introduce detectable
miRNAs in human plasma.
The synthetic miRNAs cannot survive herb extraction procedures. Compared with heat and
mechanical treatment, exposure to enzymatic environment might be the main cause of miRNA
degradation. The methylation of plant miRNAs might enhance their ability against degradation,
while being associated with other plant molecules could be a more efficient way for miRNA protection.
Supplementary Materials: Supplementary materials are available online. Figure S1: Standard curves generated
in qRT-PCR analysis.
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